Is GKB Ophthalmics Ltd (GKB) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that GKB Ophthalmics Ltd is a below average quality company .

Is GKB Ophthalmics Ltd (GKB) undervalued or overvalued?

The key valuation ratios of GKB Ophthalmics Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is GKB Ophthalmics Ltd (GKB) share price return in the past 10 years?

GKB Ophthalmics Ltd share price has declined -0.2% annually (CAGR) over the past ten years.

Is GKB Ophthalmics Ltd (GKB) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of GKB Ophthalmics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of GKB Ophthalmics Ltd (GKB)?

Company share prices are keep on changing according to the market conditions. The current trading price of GKB Ophthalmics Ltd (GKB) on 17-Apr-2026 16:59:59 at 16:59 is 71.72.

What is the P/E ratio of GKB Ophthalmics?

The latest standalone P/E ratio of GKB Ophthalmics as of 17-Apr-2026 is 0.00.

What is the P/B ratio of GKB Ophthalmics Ltd (GKB)?

The latest standalone P/B ratio of GKB Ophthalmics Ltd (GKB) as of 17-Apr-2026 is 2.28.

What is the 52-week high and low of GKB Ophthalmics Ltd (GKB)?

The 52-week high of GKB Ophthalmics Ltd (GKB) is Rs. 91.70 and the 52-week low is Rs. 45.25.

GKB Ophthalmics Ltd (GKB) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: GKB Ophthalmics Ltd (GKB)
Brand: GKB Ophthalmics

GKB Ophthalmics Ltd (GKB) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

GKB Ophthalmics Ltd (GKB)

BSE: 533212 NSE: GKB

Key Metrics

Market Cap

₹36 Cr.

P/E Ratio

0.00

Price to Book (P/B)

2.28

Price to Sales (P/S)

1.31

EV/EBITDA

54.45

Return on Capital Employed (ROCE)

-11.72%

Current Price

₹71.7

Return on Equity (ROE)

-29.32%

Return on Assets (ROA)

-11.59%

Operating Profit Margin

-10.6%

Net Profit Margin

-18.65%

Gross Profit Margin

-10.4%

Book Value per Share

₹31.5

Sales Growth (YoY)

5.04%

Sales Growth (3 Years)

6.58%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹45 / 92

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

51.13%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of GKB Ophthalmics Ltd?

GKB Ophthalmics Ltd revenue growth is 5% for FY-2025 , which is below its 5 year CAGR of 5.1% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of GKB Ophthalmics Ltd?

Promoters hold 51.13% of the GKB Ophthalmics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of GKB Ophthalmics Ltd vs industry peers?

GKB Ophthalmics Ltd revenue CAGR is 5.08% , compared to the industry median CAGR of 1.45% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does GKB Ophthalmics Ltd belong to?

GKB Ophthalmics Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.

Q.1 Stock return of GKB Ophthalmics Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 0.7% based on the current price.

DeciZen - make an informed investing decision on GKB Ophthalmics

Based on:

Data

M-Cap below 100cr DeciZen not available

GKB Ophthalmics stock performance

Key Ratios

Is GKB Ophthalmics Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	64%	6.5%	-4.1%	-4.6%	-6.3%	-2.1%	-2.2%	-3.8%	-4.8%	-11.7%	-
Value Creation Index ⓘ	3.6	-0.5	-1.3	-1.3	-1.5	-1.2	-1.2	-1.3	-1.4	-1.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	31.2	38.3	36.9	30.5	25.6	21.3	27.1	27.7	31.2	32.8	28
Sales YoY Gr.	-	22.9%	-3.7%	-17.5%	-16.1%	-16.5%	26.8%	2.5%	12.4%	5%	-
Adj EPS ⓘ	-3	-3.4	-6.4	-8.1	-8.5	-2.9	-4.7	-5.9	-7	-12.1	-8.3
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	69.7	71.2	64.9	68.5	69.9	65	60.3	54.6	47.6	35.1	31.5
Adj Net Profit ⓘ	-1.2	-1.4	-2.7	-3.8	-4.3	-1.5	-2.4	-3	-3.5	-6.1	-4
Cash Flow from Ops. ⓘ	-11.9	-4.2	-3.7	5.3	6.1	2.1	2.3	-1.1	1.4	-5	-
Debt/CF from Ops. ⓘ	-0.6	-1.7	-2.7	1.9	1.6	5.7	5	-9.8	8.1	-3.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	0.6%	5.1%	6.6%	5%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	-7.4%	-12.9%	-16.6%	-26.3%
Share Price	-0.2%	-1.2%	-12.6%	-0.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-5.6	-4.9	-9.4	-12.2	-12.3	-4.3	-7.4	-10.3	-13.6	-29.4	-24.8
Op. Profit Mgn % ⓘ	-7.8	-1.1	-2.7	-3.3	-2.9	-1.3	-1.5	-4	-4.1	-10.6	-14.5
Net Profit Mgn % ⓘ	-4	-3.7	-7.2	-12.3	-16.8	-6.9	-8.7	-10.8	-11.2	-18.7	-15.1
Debt to Equity ⓘ	0.3	0.2	0.4	0.3	0.3	0.4	0.4	0.4	0.5	1	-
Working Cap Days ⓘ	297	236	275	328	355	383	287	258	230	234	94
Cash Conv. Cycle ⓘ	160	148	182	190	128	144	90	78	64	72	-63

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-8.3	-5
TTM Sales (₹ Cr.)	27.7	150
BVPS (₹) ⓘ	31.5	105.6
Reserves (₹ Cr.) ⓘ	11	48
P/BV ⓘ	2.28	0.68
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	45.25 / 91.70
All Time Low / High (₹)	12.25 / 209.20
Market Cap (₹ Cr.)	36.2
Equity (₹ Cr.)	5
Face Value (₹)	10
Industry PE ⓘ	163.7

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of GKB Ophthalmics - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	31.17	38.32	36.92	30.47	25.56	21.34	27.05	27.73	31.18	32.75
Operating Expenses ⓘ +	34.65	38.77	37.90	31.52	26.29	21.92	27.49	28.83	32.45	36.23
Manufacturing Costs	7.58	9.30	8.07	6.16	5.51	4.80	5.12	6.18	5.23	5.19
Material Costs	17.94	20.72	20.38	16	12.86	9.92	13.75	13.67	16.72	18.46
Employee Cost	6.22	7.07	7.42	7.56	6.21	5.81	6.92	7.45	9.22	10.88
Other Costs ⓘ	2.92	1.67	2.04	1.80	1.71	1.39	1.70	1.52	1.29	1.69
Operating Profit ⓘ	-3.48	-0.45	-0.99	-1.05	-0.73	-0.57	-0.45	-1.10	-1.27	-3.48
Operating Profit Margin (%)	-11.2%	-1.2%	-2.7%	-3.5%	-2.9%	-2.7%	-1.7%	-4.0%	-4.1%	-10.6%
Other Income ⓘ +	2.31	1.47	1.05	2.62	1.38	3.34	1.96	2.09	2.08	1.97
Exceptional Items ⓘ	21.82	2.70	0	0	0	-0.72	0	0	0	0
Interest ⓘ	1.61	1.26	1.23	1.39	1.35	1.34	1.34	1.50	1.59	1.89
Depreciation ⓘ	1.42	1.34	1.58	3.43	3.47	2.99	2.49	2.54	2.59	2.64
Profit Before Tax ⓘ	17.61	1.12	-2.74	-3.25	-4.17	-2.29	-2.31	-3.04	-3.38	-6.04
Tax ⓘ	3.95	0.36	-0.17	-0.48	0	-0.18	0	-0.16	0.04	0.07
Profit After Tax	13.66	0.76	-2.58	-2.78	-4.17	-2.11	-2.31	-2.88	-3.42	-6.11
PAT Margin (%)	43.8%	2.0%	-7.0%	-9.1%	-16.3%	-9.9%	-8.5%	-10.4%	-11.0%	-18.7%
Adjusted EPS (₹)	32.9	1.8	-6.2	-6.0	-8.3	-4.2	-4.6	-5.7	-6.8	-12.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	28.96	29.59	26.94	31.77	35.25	32.77	30.40	27.52	23.99	17.67
Share Capital ⓘ	4.15	4.15	4.15	4.64	5.04	5.04	5.04	5.04	5.04	5.04
Reserves ⓘ	24.80	25.44	22.78	27.13	30.21	27.73	25.36	22.48	18.95	12.63
Debt +	7.15	7.12	9.88	10.04	9.99	11.32	11.24	10.82	10.63	16.73
Long Term Debt	0.13	0.07	0.02	0	0	1	1.62	1.17	0.64	7.25
Short Term Debt	7.02	7.05	9.86	10.04	9.99	10.32	9.62	9.65	9.99	9.48
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	5.88	6.06	4.77	7.51	7.85	6.82	5.98	5.21	7.23	6.98
Others Liabilities ⓘ	5.55	7.98	3.83	9.59	7.33	9.69	10.01	9.34	10.28	11.84
Total Liabilities ⓘ	47.54	50.74	45.42	58.90	60.42	60.60	57.63	52.89	52.13	53.22
Fixed Assets
Net Fixed Assets ⓘ +	12.49	16.43	16.98	24.29	24.83	22.28	21.27	17.28	15.89	14.44
Gross Block	28.32	33.01	34.76	45.25	49.22	42.35	43.17	41.58	42.66	43.42
Accumulated Depreciation	15.83	16.57	17.79	20.96	24.39	20.07	21.90	24.30	26.76	28.98
CWIP ⓘ	0.57	0.57	0.24	0	0	1.23	3.29	3.82	3.78	3.78
Investments ⓘ	10.45	3.77	0.66	0.32	3.21	12.22	11.90	11.90	11.90	11.90
Inventories	14.02	16.07	14.84	6.79	4.70	6.98	5.34	6.06	4.69	6.08
Trade Receivables	7.91	7.35	10.44	10.81	10.37	7.44	6	4.88	6.86	7.49
Cash Equivalents	0.72	0.75	0.39	6.61	10.36	2.10	1.43	0.41	0.70	0.89
Others Assets ⓘ	1.38	5.80	1.88	10.08	6.96	8.35	8.40	8.53	8.31	8.64
Total Assets ⓘ	47.54	50.74	45.42	58.90	60.42	60.60	57.63	52.89	52.13	53.22

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-11.90	-4.20	-3.71	5.31	6.13	2.11	2.33	-1.14	1.36	-5.04
PBT ⓘ	17.61	1.12	-2.74	-3.25	-4.17	-2.29	-2.31	-3.04	-3.38	-6.04
Adjustment ⓘ	-19.08	-0.65	2.80	3.30	4.14	2.13	2.25	2.34	2.23	2.79
Changes in Working Capital ⓘ	-3.46	-3.37	-3.65	5.3	6.18	2.27	2.4	-0.41	2.52	-1.76
Tax Paid ⓘ	-6.97	-1.30	-0.12	-0.03	-0.01	-0	-0.01	-0.04	-0.01	-0.03
Cash Flow From Investing Activity ⓘ +	14.74	5.50	2.28	-8.63	-5.68	-11.52	-0.83	2.40	0.37	-0.16
Capex	-1.93	-4.88	-1.56	-9.66	-3.66	-2.81	-3.68	1.39	-1.20	-1.39
Net Investments	15.86	9.38	3.11	0.35	-0.02	-0.79	1	0.24	-0.29	-0.30
Others ⓘ	0.81	1	0.73	0.67	-2	-7.92	1.84	0.77	1.86	1.53
Cash Flow From Financing Activity ⓘ +	-2.81	-1.29	1.41	9.21	3.31	0.61	-1.50	-2.03	-1.74	5.12
Net Proceeds from Shares ⓘ	0	0	0	7.55	4.65	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-1.32	-0.07	-0.07	-0.05	0.03	1.61	0.48	-0.56	-0.48	7.52
Interest Paid ⓘ	-1.42	-1.26	-1.23	-1.37	-1.33	-1.32	-1.28	-1.49	-1.60	-1.89
Dividend Paid ⓘ	0	0	0	0	0	0	0	-0	0	0
Others ⓘ	-0.08	0.03	2.71	3.08	-0.04	0.33	-0.70	0.03	0.34	-0.51
Net Cash Flow ⓘ	0.02	-0	-0.02	5.88	3.76	-8.80	-0	-0.78	-0	-0.07

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	61.74	2.6	-9.11	-9.47	-12.45	-6.2	-7.31	-9.95	-13.27	-29.32
ROCE (%)	63.97	6.51	-4.11	-4.56	-6.27	-2.11	-2.24	-3.81	-4.83	-11.72
Asset Turnover Ratio	0.69	0.83	0.78	0.58	0.43	0.35	0.46	0.5	0.59	0.62
PAT to CFO Conversion(x)	-0.87	-5.53	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	124	68	87	127	151	152	91	72	69	80
Inventory Days	162	135	151	130	82	100	83	75	63	60
Payable Days	220	105	97	140	218	270	170	149	136	140

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

GKB Ophthalmics Ltd FAQs

The current trading price of GKB Ophthalmics on 17-Apr-2026 16:59 is ₹71.72.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of GKB Ophthalmics stood at ₹36.15 Cr

The latest P/E ratio of GKB Ophthalmics as of 16-Apr-2026 is 0.00.

The latest P/B ratio of GKB Ophthalmics as of 16-Apr-2026 is 2.28.

The 52-week high of GKB Ophthalmics is ₹91.70 and the 52-week low is ₹45.25.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of GKB Ophthalmics is ₹27.67 ( Cr.) .

About GKB Ophthalmics Ltd

GKB Ophthalmics Limited is a public limited company domiciled in India and was incorporated on December 10, 1981 under the provisions of the Companies Act, 1956. Its registered and principal office of business is located at 16-A, Tivim Industrial Estate, Mapusa, Goa, India.

Business area of the company

The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

GKB Ophthalmics Ltd (GKB) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

GKB Ophthalmics Share Price